Filing Details
- Accession Number:
- 0001127602-24-027044
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-12 16:48:15
- Reporting Period:
- 2024-11-11
- Accepted Time:
- 2024-11-12 16:48:15
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1520262 | Alkermes Plc. | ALKS | Pharmaceutical Preparations (2834) | 981007018 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1730048 | C. Craig Hopkinson | 900 Winter St. Waltham MA 02451 | Evp R&D, Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Acquisiton | 2024-11-11 | 43,058 | $20.03 | 142,296 | No | 4 | M | Direct | |
Ordinary Shares | Disposition | 2024-11-11 | 58,996 | $30.08 | 83,300 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Ordinary Shares | Employee Stock Option (Right to Buy) | Disposition | 2024-11-11 | 43,058 | $0.00 | 43,058 | $20.03 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
129,174 | 2030-02-20 | No | 4 | M | Direct |
Footnotes
- This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/14/2023.
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/14/2023.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.20. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request.
- These options are fully vested in accordance with their terms.